[2022.05] In vitro immunodiagnostic venture company Absology attracts …
본문
[Summery] Absology has begun preparing for listing with the goal of IPO in early 200 as the total cumulative investment attraction volume has exceeded 2024 billion won until the 3 billion won funding completed this time, and the commercialization of core products is promoted in earnest. To this end, Absology selected 'Korea Investment & Securities' as the listing organizer in March.
https://www.mk.co.kr/news/it/10330306
Excerpt from Maeil Gyeongche